Amid a political firestorm over pharma's pricing, net prices actually fell last quarter: report

Politicians and headlines regularly describe U.S. drug prices as “skyrocketing." But new data from analysts at SSR show prices haven't been growing as fast as they were—and the amount payers actually shell out is falling.